Cetuximab Pharmacokinetics Influences Progression-Free Survival of Metastatic Colorectal Cancer Patients

Abstract : An ancillary phase II study was conducted to study interindividual variability in cetuximab pharmacokinetics and its influence on progression-free survival (PFS) in metastatic colorectal cancer patients cotreated with irinotecan and 5-fluorouracil.
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-01769933
Contributor : Nicolas Azzopardi <>
Submitted on : Wednesday, April 18, 2018 - 2:32:10 PM
Last modification on : Thursday, July 11, 2019 - 4:04:02 PM

Links full text

Identifiers

Citation

Nicolas Azzopardi, Thierry Lecomte, David Ternant, Michelle Boisdron-Celle, Friedrich Piller, et al.. Cetuximab Pharmacokinetics Influences Progression-Free Survival of Metastatic Colorectal Cancer Patients. Clinical Cancer Research, American Association for Cancer Research, 2011, 17 (19), pp.6329 - 6337. ⟨10.1158/1078-0432.CCR-11-1081⟩. ⟨hal-01769933⟩

Share

Metrics

Record views

144